Back to all studies
Active Not RecruitingNCT06791122

Effectiveness of an Investigational Digital Therapeutic in schizophrenia

This study is active but not recruiting in the United States. It is testing an Investigational Digital Therapeutic for schizophrenia.

SchizophreniaBehavioralOver 18 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06791122. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

What is this study testing?

This study is testing whether a digital tool or app may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may use a digital tool or app, complete questionnaires or follow-up assessments, attend study visits with the research team. The registry lists locations in United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about whether participation can be remote and what device access is needed, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a university, with sites including Sun Valley Behavioral Med Center in Imperial, University of California San Diego in La Jolla, and North Country Clinical Research Inc in Oceanside. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and having access to the required digital tools. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard numbered clinical-trial phase.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: January 23, 2025
Recruitment status
Active Not Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Boehringer Ingelheim
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioral / psychological / psychosocial
Study phase
Not clearly listed
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06791122
Official title
A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06791122. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Taking part may help test a support approach in real life.

It requires regular follow-up, often through questionnaires or interviews.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring digital app or tool for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

What is a behavioral study?

This appears to be a behavioral / psychological / psychosocial study. Phase is mainly useful to check for medication studies and some device studies.

Who might this study be for?

This study may concern people with schizophrenia; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

Could this study affect my mood, habits, motivation, or stress?

Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Boehringer Ingelheim, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that the study is active but not currently recruiting. This usually means participants may already be involved, but new participants may not be accepted.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me